PL439403A1 - <sub>Pochodna cisplatyny o cytotoksyczności kontrolowanej światłem UV/VIS, sposób jej wytwarzania oraz zastosowanie w terapii antynowotworowej</sub> - Google Patents
<sub>Pochodna cisplatyny o cytotoksyczności kontrolowanej światłem UV/VIS, sposób jej wytwarzania oraz zastosowanie w terapii antynowotworowej</sub>Info
- Publication number
- PL439403A1 PL439403A1 PL439403A PL43940321A PL439403A1 PL 439403 A1 PL439403 A1 PL 439403A1 PL 439403 A PL439403 A PL 439403A PL 43940321 A PL43940321 A PL 43940321A PL 439403 A1 PL439403 A1 PL 439403A1
- Authority
- PL
- Poland
- Prior art keywords
- cytotoxicity
- production
- controlled
- application
- anticancer therapy
- Prior art date
Links
- 238000011319 anticancer therapy Methods 0.000 title 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical class N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 title 1
- 230000003013 cytotoxicity Effects 0.000 title 1
- 231100000135 cytotoxicity Toxicity 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Przedmiotem zgłoszenia jest nowa pochodna cisplatyny o cytotoksyczności kontrolowanej światłem UV/VIS, sposób jej wytwarzania i zastosowanie w terapii antynowotworowej.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL439403A PL245357B1 (pl) | 2021-11-02 | 2021-11-02 | Pochodna cisplatyny o cytotoksyczności kontrolowanej światłem UV/VIS, sposób jej wytwarzania oraz zastosowanie w terapii antynowotworowej |
| EP22461625.0A EP4174079B1 (en) | 2021-11-02 | 2022-10-21 | Cisplatin derivative with uv / vis light-controlled cytotoxicity , method of producing thereof and its use in anti-cancer therapy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL439403A PL245357B1 (pl) | 2021-11-02 | 2021-11-02 | Pochodna cisplatyny o cytotoksyczności kontrolowanej światłem UV/VIS, sposób jej wytwarzania oraz zastosowanie w terapii antynowotworowej |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL439403A1 true PL439403A1 (pl) | 2023-05-08 |
| PL245357B1 PL245357B1 (pl) | 2024-07-08 |
Family
ID=84537013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL439403A PL245357B1 (pl) | 2021-11-02 | 2021-11-02 | Pochodna cisplatyny o cytotoksyczności kontrolowanej światłem UV/VIS, sposób jej wytwarzania oraz zastosowanie w terapii antynowotworowej |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP4174079B1 (pl) |
| PL (1) | PL245357B1 (pl) |
-
2021
- 2021-11-02 PL PL439403A patent/PL245357B1/pl unknown
-
2022
- 2022-10-21 EP EP22461625.0A patent/EP4174079B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PL245357B1 (pl) | 2024-07-08 |
| EP4174079B1 (en) | 2024-04-24 |
| EP4174079A1 (en) | 2023-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019310335A8 (en) | Methods of treating cancer with PI3K inhibitor, GDC-0077 | |
| BR112015019432A2 (pt) | Compostos de tubulisina, métodos de produção e uso | |
| MX2020002823A (es) | Fluorofenil beta-hidroxietilaminas y su uso en el tratamiento de la hiperglucemia. | |
| AR075982A1 (es) | Terapia de combinacion de un anticuerpo afucosilado y una o mas de las citoquinas seleccionadas de gm- csf humano, m -csf humano y/o il-3 humano y composicion | |
| MX2022008478A (es) | Combinaciones de brimonidina de dosis baja y usos de las mismas. | |
| EP4356962A3 (en) | Selective il-6-trans-signalling inhibitor compositions | |
| ECSP19018116A (es) | 1arilnaftiridin3carboxamidas 7sustituidas y su uso | |
| MX388736B (es) | Tratamiento de rescate de nausea y vomito post operatorio. | |
| MX361880B (es) | Composicion antifungica topica para el tratamiento de onicomicosis. | |
| MX2018015208A (es) | Andrografolido para tratar formas progresivas de esclerosis multiple. | |
| AT15455U3 (de) | Pflanzen-aufzuchtschrank | |
| JP1771868S (ja) | 美容装置 | |
| MX2021012512A (es) | Tratamiento para la migra?a. | |
| WO2018178497A3 (es) | Uso de melatonina para el tratamiento de tumores | |
| JP1750189S (ja) | 美顔器 | |
| JP1750193S (ja) | 美顔器 | |
| MX2025009920A (es) | Nano-particulas de menaquinona-9 y metodos de tratamiento | |
| RU2013112392A (ru) | Способ лечения заболеваний пародонта | |
| MX2023006765A (es) | Metodo para proporcionar terapia de celiprolol a un paciente. | |
| UA126148U (uk) | Спосіб лікування періімплантного мукозиту | |
| RU2009113089A (ru) | Способ лечения вульгарных угрей | |
| UA117620U (uk) | Спосіб лікування оперізувального лишаю | |
| UA115906U (xx) | Ефективний спосіб виготовлення дезінфектанту пролонгованої дії для стерилізації поверхонь | |
| UA107460U (uk) | Спосіб комплексного лікування захворювань пародонта у працівників, зайнятих на шкідливому виробництві | |
| RU2014150855A (ru) | Способ лечения сексуальной дисфункции у пациентов с хроническим простатитом |